Knowledge Synergies Between Small Innovators Can Accelerate Drug Development, Experts Speak Out
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - It may sound too idealistic but Israel Makov, Teva's former chief executive, believes the present drought of late-stage pipeline drugs can be filled if smaller companies doing research in "silos" share their specialized insights and form single entities to develop future drugs